Immunoglobulin Replacement vs Prophylactic Antibiotics for Hypogammaglobulinemia Secondary to Hematological Malignancy

In this randomized controlled feasibility trial conducted in seven hospitals in Australia and New Zealand, scientists enrolled patients with secondary hypogammaglobulinemia with either a history of recurrent/severe infection or an immunoglobulin G level less than 4 g/L.